Berry Genomics Co. Ltd. Class A 000710

SZSE · China · Health Technology

CNY 10.87+0.99 (+10.02%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Company news

Yahoo FinanceOct 20, 2025

China DNA Sequencing Research Report 2025: Market to Reach $3.1 Billion by 2030, Dominated by BGI, Novogene, Berry Genomics, Annoroad Gene Technology, and Burning Rock Dx

The Chinese DNA sequencing market is expanding rapidly due to rising demand for precision medicine, technological advancements, and government investments. Key opportunities lie in oncology diagnostics, reproductive health, infectious disease surveillance, and large-scale genomics, driven by companies like BGI and Novogene.Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "The Chinese Market for DNA Sequencing" report has been added to ResearchAndMarkets.com's offering. The Chinese DNA sequencing ma

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.